FDA Adverse Event Death Summary report: N

REVIVE SE 4.5MM OUS

MDR report key: 10092607 · Received May 27, 2020

Report

Report Number
3008114965-2020-00206
Event Type
Death
Date Received
May 27, 2020
Date of Event
January 31, 2013
Report Date
May 5, 2020
Manufacturer
MEDOS INTERNATIONAL SARL
Product Code
DXE
PMA / PMN Number
UNK
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # (B)(4). SINCE THE PRODUCT WAS NOT RETURNED FOR ANALYSIS, NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED AND NO DETERMINATION OF POSSIBLE CONTRIBUTING FACTORS COULD BE MADE. DEVICE HISTORY RECORD (DHR) REVIEW CANNOT BE CONDUCTED BECAUSE NO LOT NUMBER WAS PROVIDED BY THE CUSTOMER. INFORMATION REGARDING PATIENT WEIGHT, HEIGHT, MEDICAL HISTORY, RACE, AND ETHNICITY WAS NOT REPORTED. CERENOVUS MANUFACTURER'S REPORT NUMBERS: 3008114965-2020-00200, 3008114965-2020-00201, 3008114965-2020-00202, 3008114965-2020-00203, AND 3008114965-2020-00205 ARE RELATED TO THE SAME INCIDENT.

Description of Event or Problem · 1

THIS COMPLAINT IS FROM A LITERATURE SOURCE. AS REPORTED IN THE LITERATURE PUBLICATION ENTITLED, ¿MECHANICAL THROMBECTOMY FOR ISCHAEMIC STROKE: THE FIRST UK CASE SERIES¿ 1 PATIENT WITH ACUTE ISCHEMIC STROKE WHO UNDERWENT ENDOVASCULAR TREATMENT WITH THROMBECTOMY DIED DUE TO RECURRENT STROKE IN THE OTHER HEMISPHERE. PURPOSE: ENDOVASCULAR TREATMENTS HAVE THE POTENTIAL TO ACCELERATE REPERFUSION IN ACUTE ISCHAEMIC STROKE WITH LARGE VESSEL OCCLUSION. RESULTS OF THE FIRST 106 ENDOVASCULAR TREATMENTS (EVT) IN THE UK WERE PRESENTED IN THE ARTICLE. METHODS: FROM DECEMBER 2009 TO JANUARY 2013 106 PATIENTS (MEAN AGE 64 YEARS, MEDIAN BASELINE NIHSS 18) WERE TREATED WITH EVT (THROMBECTOMY ± IAT 83%, IAT (INTRA-ARTERIAL THROMBOLYSIS) ALONE 13%, NEITHER 4%).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
557097 REVIVE SE 4.5MM OUS EMBOLECTOMY CATHETER DXE MEDOS INTERNATIONAL SARL

Patients

Seq Age Sex Outcome Treatment
1 64 YR Death